Predictions
International Flavors & Fragrances Inc.
Start price
Target price
Perf. (%)
€106.00
08.02.21
08.02.21
-
08.02.22
08.02.22
13.26%
21.04.21
21.04.21
Risky Investment
Morgan Stanley
Start price
Target price
Perf. (%)
€61.03
08.02.21
08.02.21
€77.00
08.02.22
08.02.22
52.66%
30.01.22
30.01.22
Market Leader or Top 3
Well known brand
Significant cyclical dependencies
High valuation
Ocugen Inc.
Start price
Target price
Perf. (%)
€11.35
08.02.21
08.02.21
€8.00
08.02.22
08.02.22
-30.04%
11.02.21
11.02.21
Stable Large shareholder and/or long term investor
Capable Management
Little innovation
Few uniques
Fresenius SE & Co. KGaA
Start price
Target price
Perf. (%)
€34.83
08.02.21
08.02.21
€41.00
16.07.21
16.07.21
27.92%
16.07.21
16.07.21
Could be worthwhile Investment >10% per year
Fair valuation
High dividend yield expected
Small challenges to pay loans and raise capital
CRH Medical Corp
Start price
Target price
Perf. (%)
€3.22
08.02.21
08.02.21
€3.00
08.02.22
08.02.22
-0.62%
22.02.21
22.02.21
Good culture
Probably not worthwhile Investment
Little innovation
No uniques
Curevac N.V.
Start price
Target price
Perf. (%)
€105.96
08.02.21
08.02.21
-
08.02.22
08.02.22
2.02%
28.04.21
28.04.21
Could be worthwhile Investment >10% per year
Top 10 in its market
Ballard Power Systems Inc.
Start price
Target price
Perf. (%)
€32.82
08.02.21
08.02.21
€40.00
08.02.22
08.02.22
-75.16%
08.02.22
08.02.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Rising EBIT margin expected
Coca-Cola Co.
Start price
Target price
Perf. (%)
€41.33
08.02.21
08.02.21
€45.00
08.02.22
08.02.22
10.74%
29.03.21
29.03.21
Could be worthwhile Investment >10% per year
Some uniques
Top 10 in its market
Known brand
Xiaomi Corp.
Start price
Target price
Perf. (%)
€2.90
08.02.21
08.02.21
-
08.02.22
08.02.22
-35.41%
09.02.22
09.02.22
Could be worthwhile Investment >10% per year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Carbios S.A.
Start price
Target price
Perf. (%)
€55.30
08.02.21
08.02.21
-
18.01.25
18.01.25
-52.35%
12.01.24
12.01.24
Could be worthwhile Investment >10% per year
Nokia Corp.
Start price
Target price
Perf. (%)
€3.57
08.02.21
08.02.21
€5.00
-6.41%
22.02.21
22.02.21
Could be very worthwhile Investment >20% year
positive Cash Flow expected
Top Rating
Leading role in innovation
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€3.44
08.02.21
08.02.21
€5.00
08.02.22
08.02.22
-27.31%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
Star Equity Holdings Inc.
Start price
Target price
Perf. (%)
€3.12
08.02.21
08.02.21
€5.00
08.02.22
08.02.22
14.10%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
InVivo Therapeutics Holdings
Start price
Target price
Perf. (%)
€32.25
08.02.21
08.02.21
€50.00
08.02.22
08.02.22
6.98%
22.02.21
22.02.21
Could be worthwhile Investment >10% per year
Nuwellis Inc.
Start price
Target price
Perf. (%)
€7.35
08.02.21
08.02.21
€9.00
08.02.22
08.02.22
-1.36%
22.02.21
22.02.21
Could be very worthwhile Investment >20% year
Overstock.com
Start price
Target price
Perf. (%)
€79.50
08.02.21
08.02.21
-
08.02.22
08.02.22
-13.48%
27.07.21
27.07.21
Stable Large shareholder and/or long term investor
EBIT decline/stagnation expected
Few uniques
Sustainability is little important
eHealth Inc.
Start price
Target price
Perf. (%)
€48.35
08.02.21
08.02.21
-
08.02.22
08.02.22
16.56%
24.03.21
24.03.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Synaptics Inc.
Start price
Target price
Perf. (%)
€98.50
08.02.21
08.02.21
-
08.02.22
08.02.22
17.77%
24.03.21
24.03.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bill.com Holdings Inc.
Start price
Target price
Perf. (%)
€152.00
08.02.21
08.02.21
-
08.02.22
08.02.22
-20.39%
24.03.21
24.03.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
Gamestop Corp.
Start price
Target price
Perf. (%)
€14.13
08.02.21
08.02.21
-
-36.12%
21.02.21
21.02.21
Could be very worthwhile Investment >20% year